Perspectives from ISMPP Insider’s Expert Successes Initiative, a forum for sharing practical experiences and insights. As expectations for transparency and accessibility in scientific publishing continue to rise, Plain Language Summaries of Publications (PLS-Ps)...
You are a writer at a medical communications agency supporting development of the first draft of a manuscript reporting primary results from a phase 3 clinical trial. At your client’s request, you are using the pharmaceutical company’s internally developed...
Clear, accessible communication is fundamental to high-quality medical communications. That’s why ISMPP is proud to support the use of the Multi-Regional Clinical Trials (MRCT) Center’s Clinical Research Glossary, a patient-centered, consensus-driven resource...
A perspective from the 2026 European Meeting of ISMPP keynote presentation by Michael Siller, MSC, a coach and consultant with expertise in corporate culture and leadership, change management, and intercultural management Introduction In medical communications, the...
Michael Nissen, Independent Medical Publications Professional, USA; Michelle Parrish, MEDiSTRAVA, an Inizio Medical Company; Jennifer Bodkin, Envision Spark, an Envision Medical Communications Agency, Envision Pharma Group, UK; Anna Santaromita, Natera, Inc., USA; Sam...
